Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Randomized Controlled Trial of Rituximab for Refractory Nephrotic Syndrome in Children

NCT01716442 is registered in ClinicalTrials.gov with Seoul National University Childrens Hospital as lead sponsor.

NCT NCT01716442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01716442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Randomized Controlled Trial of Rituximab for Refractory Nephrotic Syndrome in Children
Lead sponsor
Seoul National University Childrens Hospital
Phase
Phase 2/3
Overall status
Unknown status
Start date
August 31, 2012
Completion date
November 30, 2013
Enrollment
88 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

steroid dependent nephrotic syndrome, steroid resistant nephrotic syndrome